Short Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Increases By 45.0%
Short Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Increases By 45.0%
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 130,200 shares, an increase of 45.0% from the December 31st total of 89,800 shares. Based on an average daily volume of 101,000 shares, the short-interest ratio is currently 1.3 days.
Global X Genomics & Biotechnomics ETF(纳斯达克股票代码:GNOM — Get Rating)是1月份空头利率大幅增加的受益者。截至1月15日,空头利率共计130,200股,较12月31日的89,800股总额增长了45.0%。根据10.1万股的平均每日成交量,目前空头利率为1.3天。
Hedge Funds Weigh In On Global X Genomics & Biotechnology ETF
对冲基金加大对Global X基因组学和生物技术ETF的看法
Hedge funds and other institutional investors have recently modified their holdings of the business. Simplex Trading LLC boosted its stake in shares of Global X Genomics & Biotechnology ETF by 198.6% during the third quarter. Simplex Trading LLC now owns 2,311 shares of the company's stock valued at $29,000 after purchasing an additional 1,537 shares in the last quarter. FORVIS Wealth Advisors LLC acquired a new stake in Global X Genomics & Biotechnology ETF in the third quarter valued at approximately $150,000. Avidian Wealth Solutions LLC boosted its stake in Global X Genomics & Biotechnology ETF by 6.8% in the second quarter. Avidian Wealth Solutions LLC now owns 12,302 shares of the company's stock valued at $150,000 after acquiring an additional 788 shares in the last quarter. Stelac Advisory Services LLC boosted its stake in Global X Genomics & Biotechnology ETF by 71.2% in the second quarter. Stelac Advisory Services LLC now owns 12,742 shares of the company's stock valued at $156,000 after acquiring an additional 5,301 shares in the last quarter. Finally, Beaumont Financial Advisors LLC acquired a new stake in Global X Genomics & Biotechnology ETF in the fourth quarter valued at approximately $166,000.
对冲基金和其他机构投资者最近修改了他们对该业务的持股。Simplex Trading LLC在第三季度将其在Global X Genomics与生物技术ETF的股份增加了198.6%。Simplex Trading LLC在上个季度又购买了1,537股股票后,现在拥有该公司2311股股票,价值29,000美元。FORVIS Wealth Advisors LLC在第三季度收购了Global X Genomics与生物技术ETF的新股份,价值约15万美元。Avidian Wealth Solutions LLC在第二季度将其在Global X基因组学和生物技术ETF中的股份增加了6.8%。Avidian Wealth Solutions LLC在上个季度又收购了788股股票后,现在拥有该公司12,302股股票,价值15万美元。Stelac Advisory Services LLC在第二季度将其在Global X基因组学和生物技术ETF中的股份增加了71.2%。Stelac Advisory Services LLC在上个季度又收购了5,301股股票后,现在拥有该公司12,742股股票,价值15.6万美元。最后,Beaumont Financial Advisors LLC在第四季度收购了Global X Genomics与生物技术ETF的新股份,价值约16.6万美元。
Global X Genomics & Biotechnology ETF Price Performance
Global X 基因组学和生物技术 ETF 价格表现
Shares of NASDAQ GNOM traded up $0.12 during midday trading on Friday, reaching $13.83. 64,314 shares of the company's stock traded hands, compared to its average volume of 69,001. The stock's 50 day simple moving average is $13.08 and its 200-day simple moving average is $13.45. Global X Genomics & Biotechnology ETF has a one year low of $10.48 and a one year high of $17.02.
纳斯达克GNOM的股价在周五午盘交易中上涨了0.12美元,达到13.83美元。该公司的股票交易量为64,314股,而平均交易量为69,001股。该股的50天简单移动平均线为13.08美元,其200天简单移动平均线为13.45美元。Global X基因组与生物技术ETF创一年低点10.48美元,一年高点为17.02美元。
Global X Genomics & Biotechnology ETF Company Profile
Global X 基因组学与生物技术 ETF 公司简介
Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research.
Complete Genomics, Inc是一家生命科学公司,已开发并商业化了脱氧核糖核酸(DNA)测序平台。其完整的基因组分析平台 (CGA) 平台将其人类基因组测序技术与先进的信息学和数据管理软件以及端到端的外包服务模型相结合,为其客户提供可用于基于基因组的研究的数据。
See Also
另见
- Get a free copy of the StockNews.com research report on Global X Genomics & Biotechnology ETF (GNOM)
- MarketBeat Week in Review – 1/23- 1/27
- Why Lucid Spiked Nearly 100% In One Day
- Ride These Railroad Stocks for Growth and Income
- ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
- KLA Corporation: Strength In A Troubled Semi-Market
- 免费获取 StockNews.com 关于 Global X 基因组学和生物技术ETF(GNOM)的研究报告
- MarketBeat Week 回顾 — 1/23-1/27
- 为什么 Lucid 在一天之内飙升了近 100%
- 利用这些铁路股票实现增长和收入
- ASML 预计今年对芯片的需求将上涨,提振了销售前景
- KLA 公司:在陷入困境的半市场中的实力
Receive News & Ratings for Global X Genomics & Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收Global X基因组学和生物技术ETF的新闻和评级 -在下面输入您的电子邮件地址,通过Marketbeat.com的免费每日电子邮件时事通讯接收Global X Genomics与生物技术ETF及相关公司的最新新闻和分析师评级的简明每日摘要。